The NIAID has a long-standing commitment to conduct research on Lyme borreliosis, or Lyme disease. The major goals of the NIAID Lyme Disease Research Program are to develop better means of diagnosing, treating, and preventing this disease. To accomplish these objectives, the NIAID Lyme disease research portfolio includes a broad range of activities designed to increase our understanding of this disease. Learn more about NIAID's Lyme disease research.
Volunteer for NIAID-funded clinical studies related to Lyme disease on ClinicalTrials.gov.
NIAID Media availablity: Antibodies Protect Mice from Developing Respiratory Tularemia—June 27, 2007
Scientists Reveal How Disease Bacterium Survives Inside Immune System Cell—May 5, 2005
All Tickborne Diseases News Releases
In 1982, NIAID scientist Willy Burgdorfer, Ph.D., identified the bacterium that causes Lyme disease. Read about the groundbreaking discovery of Borrelia burgdorferi.
View a list of links for more information about lyme disease.